专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20170049698A1 NATURAL SUPPLEMENT 审中-公开
标题翻译：自然补充
公开(公告)号：US20170049698A1
公开(公告)日：2017-02-23
申请号：US15239699
申请日：2016-08-17
申请人： Elina Fuhrman
发明人： Elina Fuhrman
IPC分类号： A61K9/00 , A61K36/48 , A61K36/23 , A61K36/906 , A61K36/235 , A61K36/31 , A61K36/81 , A61K36/185 , A61K36/53 , A61K36/9066 , A61K36/07 , A61K36/70 , A23L23/00 , A23L19/00 , A61K36/42
CPC分类号： A23L19/00 , A23L23/00 , A23V2002/00 , A61K9/0095 , A61K36/07 , A61K36/21 , A61K36/23 , A61K36/235 , A61K36/31 , A61K36/8962 , A61K36/9064 , A61K36/9066 , A61K2300/00
摘要： A supplement including a plurality of ingredients selected from one or more of vegetables, roots, herbs, spices, legumes in combination with a water broth, the plurality of ingredients selected for a nutritional benefit. A method including combining a plurality of ingredients selected from one or more of vegetables, roots, herbs, spices, legumes with a water broth, the plurality of ingredients selected for a nutritional benefit; and simmering the combination for a time period sufficient to release nutrients from the plurality of ingredients.
摘要翻译：一种补充剂，其包括选自蔬菜，根，香草，香料，豆类与水肉汤中的一种或多种的成分，所述多种成分选择用于营养益处。一种方法，包括将选自蔬菜，根，草药，香料，豆类中的一种或多种的成分与水肉汤混合，选择用于营养益处的多种成分; 以及将所述组合煨煮足以从所述多种成分中释放营养物质的时间段。

2. 发明授权

US09498508B2 Pharmaceutical composition for treating cancers and preparation method therefor 有权
公开(公告)号：US09498508B2
公开(公告)日：2016-11-22
申请号：US14846786
申请日：2015-09-06
申请人： Mingchun Xiao
发明人： Mingchun Xiao
IPC分类号： A01N65/00 , A61K36/9068 , A61K36/752 , A61K36/804 , A61K36/85 , A61K36/884 , A61K36/888 , A61K36/8884 , A61K36/8888 , A61K36/8945 , A61K36/8988 , A61K36/8998 , A61K36/9062 , A61K36/9064 , A61K36/9066 , A61K36/46 , A61K36/481 , A61K36/484 , A61K36/53 , A61K36/54 , A61K36/575 , A61K36/68 , A61K36/71 , A61K36/714 , A61K36/734 , A23F3/16 , A61K36/076 , A61K36/232 , A61K36/233 , A61K36/284 , A61K36/48 , A61K36/482 , A61K36/532 , A61K36/535 , A61K36/538 , A61K36/539 , A61K36/65 , A61K36/66 , A61K36/88 , A61K36/8905 , A61K36/906 , A61K36/07 , A61K36/12 , A61K36/185 , A61K36/21 , A61K36/236 , A61K36/237 , A61K36/258 , A61K36/268 , A61K36/515 , A61K36/882
CPC分类号： A61K36/9068 , A23F3/163 , A61K36/07 , A61K36/076 , A61K36/12 , A61K36/185 , A61K36/21 , A61K36/232 , A61K36/233 , A61K36/236 , A61K36/237 , A61K36/258 , A61K36/268 , A61K36/284 , A61K36/46 , A61K36/48 , A61K36/481 , A61K36/482 , A61K36/484 , A61K36/515 , A61K36/53 , A61K36/532 , A61K36/535 , A61K36/538 , A61K36/539 , A61K36/54 , A61K36/575 , A61K36/65 , A61K36/66 , A61K36/68 , A61K36/71 , A61K36/714 , A61K36/734 , A61K36/752 , A61K36/804 , A61K36/85 , A61K36/88 , A61K36/882 , A61K36/884 , A61K36/888 , A61K36/8884 , A61K36/8888 , A61K36/8905 , A61K36/8945 , A61K36/8988 , A61K36/8998 , A61K36/906 , A61K36/9062 , A61K36/9064 , A61K36/9066 , A61K2300/00
摘要： A pharmaceutical composition for treating cancers and preparation method thereof. Said composition for treating cancers contains Chinese medicinal materials including Rhizoma Pinelliae, Rhizoma Arisaematis, Rhizoma Gastrodiae etc., and said preparation method is in accordance with a conventional Chinese medicinal preparation method, manufacturing said composition to form any one of the ordinary oral preparations.

3. 发明申请

US20130017280A1 COMPOSITION FOR ACCELERATING CHANGE IN MUSCLE TYPE 有权
标题翻译：用于加速肌肉类型变化的组合物
公开(公告)号：US20130017280A1
公开(公告)日：2013-01-17
申请号：US13638813
申请日：2011-04-06
申请人： Si Young Cho , Ji Hae Lee , Il Hong Bae , Min Jeong Song , Hyeon Ju Yeo , Dae Bang Seo , Wan Gi Kim , Sang Jun Lee
发明人： Si Young Cho , Ji Hae Lee , Il Hong Bae , Min Jeong Song , Hyeon Ju Yeo , Dae Bang Seo , Wan Gi Kim , Sang Jun Lee
IPC分类号： A61K36/67 , A61K31/202 , A61K36/18 , A61K36/752 , A61P21/00 , A61K36/282
CPC分类号： A61K36/481 , A61K31/202 , A61K36/00 , A61K36/185 , A61K36/282 , A61K36/355 , A61K36/424 , A61K36/44 , A61K36/488 , A61K36/537 , A61K36/54 , A61K36/67 , A61K36/70 , A61K36/73 , A61K36/752 , A61K36/815 , A61K36/882 , A61K36/9064 , A61K45/06 , A61K2300/00
摘要： The present invention provides a composition for accelerating a change in muscle type, increasing the amount of muscle, strengthening muscle, enhancing athletic abilities, reducing lipids, suppressing the accumulation of lipids, lowering blood sugar, controlling body weight or lowering body weight, containing a PPAR-δ promoter, an AMPK promoter and a PGC1-α promoter as an active ingredient
摘要翻译：本发明提供一种用于加速肌肉类型变化，增加肌肉量，增强肌肉，增强运动能力，减少脂质，抑制脂质积聚，降低血糖，控制体重或降低体重的组合物， PPAR-δ启动子，AMPK启动子和PGC1-α启动子作为活性成分

4. 发明申请

US20080311230A1 Preparation of Artemisia to treat human cancer, autoimmune disease, IgA-Nephropathy, and to counteract weight loss in cancer patients 审中-公开
标题翻译：制备艾蒿治疗人类癌症，自身免疫性疾病，IgA肾病，并减轻癌症患者的体重减轻
公开(公告)号：US20080311230A1
公开(公告)日：2008-12-18
申请号：US11764205
申请日：2007-06-17
申请人： Harun A. Omer
发明人： Harun A. Omer
IPC分类号： A61K36/282
CPC分类号： A61K36/282 , A61K36/9064 , A61K2300/00
摘要： In human cancer, reduced appetite and weight loss are serious symptoms and are difficult to manage. These symptoms not only effect the quality of life, but also reduce the tolerance and response to anti-cancer drugs, thereby effecting the prognosis and survival to disease. These symptoms are caused, among others, by overactive immune system of the body. Anti-cancer drugs that were effective in the beginning start losing their efficacy, and are less tolerated. Also in autoimmune diseases, the immune system is overreacting. This herbal invention, based on Artemisia species, ginger root and large cardamom, each targeting at different factors involved in weight loss and autoimmune diseases, is effective in improving appetite, thus counteracts the development of resistance to anti-cancer drugs, and helps in the cure of autoimmune diseases, IgA-Nephropathy, which has no cure so far.
摘要翻译：在人类癌症中，食欲降低和体重减轻是严重症状，难以管理。这些症状不仅影响生活质量，而且还降低对抗癌药物的耐受性和反应性，从而影响疾病的预后和生存。这些症状是由身体过度活跃的免疫系统引起的。开始有效的抗癌药物开始失去疗效，耐受性较差。同样在自身免疫性疾病中，免疫系统反应过度。这种草药发明基于蒿种，姜根和大豆蔻，每种针对涉及减肥和自身免疫疾病的不同因素，有效改善食欲，从而抵消抗癌药物抗性的发展，有助于治疗自身免疫性疾病，IgA肾病，迄今尚无治愈。

5. 发明申请

US20080038367A1 Nutritional supplement compositions and methods of preparing 审中-公开
标题翻译：营养补充剂组合物和制备方法
公开(公告)号：US20080038367A1
公开(公告)日：2008-02-14
申请号：US11503475
申请日：2006-08-11
申请人： Sal Saloum
发明人： Sal Saloum
IPC分类号： A61K36/752 , A61K36/45 , A61K36/53 , A61K36/534 , A61K36/328 , A61K36/48 , A61K36/28
CPC分类号： A61K36/738 , A61K36/185 , A61K36/23 , A61K36/28 , A61K36/287 , A61K36/63 , A61K36/752 , A61K36/9064 , A61K2300/00
摘要： The present invention relates to a nutritional supplement composition and methods for preparing. The invention further provides a method for creating a nutrient supplement drink composition comprising the a carrier liquid, a flower distillate, and at least one herbal extract component, and optionally including an additional ingredient selected from the group consisting of a second herbal extract component, a nutrient, a flavoring agent, a preservative, a coloring agent, a second carrier agent, and combinations thereof.
摘要翻译：本发明涉及营养补充剂组合物及其制备方法。本发明还提供了一种用于产生营养补充饮料组合物的方法，所述营养补充饮料组合物包含载体液体，花油馏出物和至少一种草药提取物组分，并且任选地包含另外的成分，所述另外的成分选自第二草药提取物组分，营养物，调味剂，防腐剂，着色剂，第二载体剂及其组合。

6. 发明授权

US06911436B2 Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same 失效
标题翻译：复合碳水化合物和精油的药物组合物及其使用方法
公开(公告)号：US06911436B2
公开(公告)日：2005-06-28
申请号：US09880907
申请日：2001-06-15
申请人： Harold G. Brown , Karen K. Brown
发明人： Harold G. Brown , Karen K. Brown
IPC分类号： A61K8/73 , A61K8/92 , A61K9/00 , A61K31/715 , A61K31/727 , A61K31/728 , A61K31/737 , A61K36/15 , A61K36/185 , A61K36/23 , A61K36/45 , A61K36/53 , A61K36/534 , A61K36/537 , A61K36/54 , A61K36/57 , A61K36/61 , A61K36/736 , A61K36/752 , A61K36/886 , A61K36/9064 , A61K36/9066 , A61K47/44 , A61Q19/00 , A61K31/725 , A61K31/70 , C08B37/00
CPC分类号： A61K47/44 , A61K8/73 , A61K8/735 , A61K8/922 , A61K9/0014 , A61K9/0019 , A61K31/715 , A61K31/727 , A61K31/728 , A61K31/737 , A61K36/15 , A61K36/185 , A61K36/23 , A61K36/45 , A61K36/53 , A61K36/534 , A61K36/537 , A61K36/54 , A61K36/57 , A61K36/61 , A61K36/736 , A61K36/752 , A61K36/886 , A61K36/9064 , A61K36/9066 , A61Q19/00 , Y10S424/13 , Y10S514/825 , Y10S514/859 , Y10S514/862 , Y10S514/865 , Y10S514/885 , Y10S514/886 , Y10S514/887 , A61K2300/00
摘要： The invention discloses the discovery that a pharmaceutical composition containing complex carbohydrates and natural or synthetic essential oils can work effectively as a topical pharmaceutical composition. Such pharmaceutical compositions reduce inflammation, assist in wound healing, protect against bruising, relieve itching, relieve pain and swelling and treat topical bacterial infections such as acne and decubitus ulcers. Such pharmaceutical compositions can be administered to mammals including humans. Also included in this invention are methods to deliver topically applied macromolecules into the tissue of mammals and methods of blocking the adhesion cascade.
摘要翻译：本发明公开了一种发现，含有复合碳水化合物和天然或合成精油的药物组合物可以作为局部药物组合物有效地起作用。这样的药物组合物减少炎症，有助于伤口愈合，防止瘀伤，缓解瘙痒，缓解疼痛和肿胀以及治疗局部细菌感染如痤疮和褥疮溃疡。这样的药物组合物可以施用于包括人在内的哺乳动物。本发明还包括将局部施用的大分子递送到哺乳动物的组织中的方法和阻断粘附级联的方法。

7. 发明授权

US06896910B2 Anti-fatigue and tonic agent containing wild ginseng 失效
标题翻译：含有野参的抗疲劳和滋补剂
公开(公告)号：US06896910B2
公开(公告)日：2005-05-24
申请号：US10055344
申请日：2002-01-25
申请人： Won Kyu Kim , Kye Won Lee , Sun Jung Lee , Bong Jun Kim , Hye Young Lee , Chul Hong Park , Dong Soo Kim , Kyeong Bum Choi , Eun Joung Yoo
发明人： Won Kyu Kim , Kye Won Lee , Sun Jung Lee , Bong Jun Kim , Hye Young Lee , Chul Hong Park , Dong Soo Kim , Kyeong Bum Choi , Eun Joung Yoo
IPC分类号： A61K36/258 , A61K35/20 , A61K35/64 , A61P1/14 , A01K35/78
CPC分类号： A61K36/11 , A61K36/068 , A61K36/232 , A61K36/234 , A61K36/254 , A61K36/258 , A61K36/284 , A61K36/296 , A61K36/342 , A61K36/344 , A61K36/46 , A61K36/481 , A61K36/484 , A61K36/65 , A61K36/704 , A61K36/725 , A61K36/746 , A61K36/804 , A61K36/815 , A61K36/8945 , A61K36/896 , A61K36/8965 , A61K36/8969 , A61K36/9064 , A61K2300/00
摘要： Disclosed is an anti-fatigue and nutritious tonic agent containing powder of wild ginseng, optionally in admixture with a herb medicine, or water extract of the powder, which has remarkably enhanced anti-fatigue, and nutrition and tonic effects as compared with agents containing cultivated ginseng.
摘要翻译：本发明涉及含有野山参粉末的抗疲劳和营养滋补剂，任选地与草药混合，或粉末的水提取物，与含有栽培物质的试剂相比，具有显着增强的抗疲劳性，营养和滋补作用参。

8. 发明授权

US6121234A Use of essential oils to increase bioavailability of orally administered pharmaceutical compounds 失效
标题翻译：使用精油提高口服药物化合物的生物利用度
公开(公告)号：US6121234A
公开(公告)日：2000-09-19
申请号：US19936
申请日：1998-02-06
申请人： Leslie Z. Benet , Vincent J. Wacher , Reed M. Benet
发明人： Leslie Z. Benet , Vincent J. Wacher , Reed M. Benet
IPC分类号： A61K31/337 , A61K36/13 , A61K36/14 , A61K36/15 , A61K36/185 , A61K36/23 , A61K36/235 , A61K36/25 , A61K36/28 , A61K36/282 , A61K36/324 , A61K36/328 , A61K36/45 , A61K36/48 , A61K36/53 , A61K36/532 , A61K36/534 , A61K36/537 , A61K36/54 , A61K36/57 , A61K36/61 , A61K36/63 , A61K36/67 , A61K36/738 , A61K36/80 , A61K36/8962 , A61K36/898 , A61K36/899 , A61K36/9064 , A61K36/9068 , A61K38/13 , A61K47/10 , A61K47/44 , A61K31/12
CPC分类号： A61K47/44 , A61K31/337 , A61K36/13 , A61K36/14 , A61K36/15 , A61K36/185 , A61K36/23 , A61K36/235 , A61K36/25 , A61K36/28 , A61K36/282 , A61K36/324 , A61K36/328 , A61K36/45 , A61K36/48 , A61K36/53 , A61K36/532 , A61K36/534 , A61K36/537 , A61K36/54 , A61K36/57 , A61K36/61 , A61K36/63 , A61K36/67 , A61K36/738 , A61K36/752 , A61K36/80 , A61K36/8962 , A61K36/898 , A61K36/899 , A61K36/9064 , A61K36/9068 , A61K38/13 , A61K47/10 , Y10S514/946
摘要： A method for increasing bioavailability and reducing inter- and intra-individual variability of an orally administered hydrophobic pharmaceutical compound, which comprises orally coadministering the pharmaceutical compound to a mammal in need of treatment with the compound with an essential oil or essential oil component in an amount sufficient to provide bioavailability of the compound in the presence of the essential oil or essential oil component greater than bioavailability of the compound in the absence of the essential oil or essential oil component, wherein the essential oil or essential oil component has an activity of at least 10% inhibition at a concentration of 0.01 wt. % or less in an assay that measures conversion of cyclosporine to hydroxylated products using an assay system containing 250 .mu.g rat liver microsomes, 1 .mu.M cyclosporine, and 1 mM reduced nicotinamide adenine dinucleotide phosphate (NADPH) in 1 ml of 0.1 M sodium phosphate buffer, pH 7.4.
摘要翻译：一种用于提高口服给药的疏水性药物化合物的生物利用度和降低个体间和个体间变异性的方法，其包括将药物化合物口服加入需要用化合物处理的哺乳动物，其中精油或精油成分的量为足以在不存在精油或精油成分的情况下提供大于化合物的生物利用度的精油或精油成分存在下化合物的生物利用度，其中精油或精油成分至少具有活性浓度为0.01重量％时抑制10％在使用含有250μg大鼠肝微粒体，1μM环孢菌素和1mM还原型烟酰胺腺嘌呤二核苷酸磷酸酯（NADPH）的测定系统测量环孢菌素至羟基化产物的1％的0.1M磷酸钠缓冲液，pH 7.4。

9. 发明授权

US5916566A Use of benzoin gum to inhibit P-glycoprotein-mediated resistance of pharmaceutical compounds 失效
标题翻译：使用安息香胶抑制P-糖蛋白介导的药物化合物抗性
公开(公告)号：US5916566A
公开(公告)日：1999-06-29
申请号：US973593
申请日：1998-02-11
申请人： Leslie Z. Benet , Vincent J. Wacher , Reed M. Benet
发明人： Leslie Z. Benet , Vincent J. Wacher , Reed M. Benet
IPC分类号： A61K9/00 , A61K31/337 , A61K36/13 , A61K36/14 , A61K36/15 , A61K36/185 , A61K36/23 , A61K36/235 , A61K36/25 , A61K36/28 , A61K36/282 , A61K36/324 , A61K36/328 , A61K36/45 , A61K36/48 , A61K36/53 , A61K36/532 , A61K36/534 , A61K36/537 , A61K36/54 , A61K36/57 , A61K36/61 , A61K36/63 , A61K36/67 , A61K36/738 , A61K36/80 , A61K36/8962 , A61K36/898 , A61K36/899 , A61K36/9064 , A61K36/9068 , A61K38/00 , A61K38/13 , A61K47/10 , A61K47/44 , A61K35/78 , A61K31/335
CPC分类号： A61K47/44 , A61K31/337 , A61K36/13 , A61K36/14 , A61K36/15 , A61K36/185 , A61K36/23 , A61K36/235 , A61K36/25 , A61K36/28 , A61K36/282 , A61K36/324 , A61K36/328 , A61K36/45 , A61K36/48 , A61K36/53 , A61K36/532 , A61K36/534 , A61K36/537 , A61K36/54 , A61K36/57 , A61K36/61 , A61K36/63 , A61K36/67 , A61K36/738 , A61K36/752 , A61K36/80 , A61K36/8962 , A61K36/898 , A61K36/899 , A61K36/9064 , A61K36/9068 , A61K38/13 , A61K47/10 , A61K9/0014
摘要： A method for increasing bioavailabilty of an orally administered hydrophobic pharmaceutical compound, which comprises orally administering the pharmaceutical compound to a mammal in need of treatment with the compound concurrently with an essential oil or essential oil component in an amount sufficient to provide bioavailability of the compound in the presence of the essential oil or essential oil component greater than bioavailability of the compound in the absence of the essential oil or essential oil component, wherein the essential oil or essential oil component has an activity of at least 10% inhibition at a concentration 0.01 wt. % or less in an assay that measures reduced conversion of cyclosporine to hydroxylated products using an assay system containing 250 .mu.g rat liver microsomes, 1 .mu.M cyclosporine, and 1 .mu.M reduced nicotinamide adenine dinucleotide phosphate (NADPH) in 1 ml of 0.1 M sodium phosphate buffer, pH 7.4.
摘要翻译： PCT No.PCT / US96 / 09607 Sec。 371日期1998年2月11日 102（e）1998年2月11日PCT PCT 1996年6月7日PCT公布。出版物WO96 / 40192 日期：1996年12月19日一种增加口服给药的疏水性药物化合物的生物利用度的方法，其包括将药物化合物口服给予需要与精油或精油成分同时处理的哺乳动物，其量足以提供在精油或精油成分存在下化合物的生物利用度大于化合物在不存在精油或精油成分时的生物利用度，其中精油或精油成分具有至少10％的抑制活性浓度为0.01wt。在使用含有250μg大鼠肝微粒体，1μM环孢菌素和1μM还原型烟酰胺腺嘌呤二核苷酸磷酸（NADPH）的测定系统测量环孢菌素至羟基化产物的转化率的测定中，％或更少，在1ml 0.1M 磷酸钠缓冲液，pH 7.4。

10. 发明授权

US5725859A Plant-based therapeutic agent with virustatic and antiviral effect 失效
标题翻译：基于植物的治疗剂，具有病毒和抗病毒作用
公开(公告)号：US5725859A
公开(公告)日：1998-03-10
申请号：US586739
申请日：1996-06-03
申请人： Osama L.M. Omer
发明人： Osama L.M. Omer
IPC分类号： A61K36/00 , A61K36/22 , A61K36/28 , A61K36/282 , A61K36/30 , A61K36/71 , A61K36/738 , A61K36/9064 , A01N65/00 , A61K35/78
CPC分类号： A61K36/71 , A61K36/22 , A61K36/28 , A61K36/30 , A61K36/738 , A61K36/9064
摘要： A method of treating a patient infected with DNA virus of the herpes family or DNA hepatitis B or hepatitis C viruses, or suffering from chronic allergic rhino-sino-bronchitis, by administering to the said patient a pharmaceutical composition comprising at least two of the compounds selected from the group consisting of absinthe (artemisia absinthium) resin of mastic (resin pistacia lenticus) fruit of delphinium denudatum and wherein one or more of the compounds selected from the group consisting of rose buds (flores rosae) seeds of cardamom (fructus ellettaria cardamomum, and borage flowers (flores onosma brateatum boriginaceae) are added.
摘要翻译： PCT No.PCT / DE95 / 00513 Sec。 371日期：1996年6月3日 102（e）日期1996年6月3日PCT提交1995年4月11日PCT公布。出版物WO95 / 29688 日期：1995年11月9日，一种治疗患有疱疹病毒DNA病毒或DNA乙型肝炎或丙型肝炎病毒或患有慢性过敏性鼻 - 支气管炎的患者的方法，该方法是向所述患者施用药物组合物，至少两种选自以下的化合物中选出的一种或多种选自以下的化合物：茜草（芫荽属）的苦楝树（蒿蒿）麝香树脂（树脂仙人掌）果实，其中一种或多种选自玫瑰花芽加入豆蔻（fructus ellettaria cardamomum）和琉璃苣花（flores onosma brateatum boriginaceae）。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式